Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chubb
Daiichi Sankyo
Baxter
Colorcon
Farmers Insurance
Citi
Cipla
Deloitte

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020668

« Back to Dashboard

NDA 020668 describes LEXXEL, which is a drug marketed by Astrazeneca and is included in one NDA. Additional details are available on the LEXXEL profile page.

The generic ingredient in LEXXEL is enalapril maleate; felodipine. There are twenty-seven drug master file entries for this compound. Additional details are available on the enalapril maleate; felodipine profile page.
Summary for 020668
Tradename:LEXXEL
Applicant:Astrazeneca
Ingredient:enalapril maleate; felodipine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength5MG;5MG
Approval Date:Dec 27, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength5MG;2.5MG
Approval Date:Oct 28, 1998TE:RLD:No

Expired US Patents for NDA 020668

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca LEXXEL enalapril maleate; felodipine TABLET, EXTENDED RELEASE;ORAL 020668-001 Dec 27, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca LEXXEL enalapril maleate; felodipine TABLET, EXTENDED RELEASE;ORAL 020668-002 Oct 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca LEXXEL enalapril maleate; felodipine TABLET, EXTENDED RELEASE;ORAL 020668-002 Oct 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca LEXXEL enalapril maleate; felodipine TABLET, EXTENDED RELEASE;ORAL 020668-001 Dec 27, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Colorcon
Argus Health
UBS
Deloitte
McKesson
US Department of Justice
Julphar
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.